AARDEX and Cambridge Cognition Partner to Improve Adherence in DCTs

Article

AARDEX Group and Cambridge Cognition have teamed up to improve adherence monitoring during hybrid and DCTs. AARDEX Group’s MEMS® dosing capture and analytics system will be intergrated with Cambridge Cognition’s Clinpal DCT platform providing sponsors and CROs with a new adherence management tool.

Read more about the partnership here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.